Primary care clinicians are on the front line of managing the H1N1 flu pandemic. This page will provide news, updates, resources, and commentary on the outbreak as it develops.
—Julie Bowen, Editor of Consultant
How are you dealing with the outbreak? Help us build this page by sending in resources, comments, and suggestions.
A15-year-old girl was referred to a pediatric endocrinologist for evaluation of hyperthyroidism. Her primary concerns were intermittent increases in heart rate and appetite (with a weight gain of 7 kg within the past year), feeling hot at night even in winter, persistent lower extremity edema that had been present since age 4 years, and difficulty in concentrating. She denied having diarrhea, sweating, fatigue, breathing difficulties, hair loss, or changes in hair texture.
For 3 days, a 7-year-old girl had severe, generalized abdominal pain. The patient described the pain as sharp and achy without radiation; she denied any relieving or aggravating factors. She also reported decreased appetite and energy for the past week.
The rash on this 4-week-old girl had appeared 5 days earlier on her face as thickened scales on an erythematous base and subsequently spread to the scalp, shoulder, chest, abdomen, and extremities. A few bullae were noted on the neck and hands. Initial treatment with cephalexin failed to control the rash, and the infant was admitted to the hospital for further evaluation.
A universal vaccine that protects against all strains of influenza virus may eventually replace yearly seasonal flu shots. This vaccine has been shown to be effective in animals, report investigators from the National Institute of Allergy and Infectious Diseases (NIAID). More »
The WHO has been accused of exaggerating the potential health consequences of the H1N1 pandemic, causing “unjustified fear” about the H1N1 virus. One possible explanation for the hysteria and hand wringing? Members of the WHO advisory committee have financial ties to pharmaceutical companies that make flu virus vaccines. More »
The WHO has been accused of exaggerating the potential health consequences of the H1N1 pandemic, causing “unjustified fear” about the H1N1 virus. One possible explanation for the hysteria and hand wringing? Members of the WHO advisory committee have financial ties to pharmaceutical companies that make flu virus vaccines. More »
Objective: To report the first documented dual infection of pandemic (H1N1) 2009 and seasonal H3N2 viruses in a human. ... influenza A antigen by an immunofluorescence assay and pandemic (H1N1) 2009 infection was confirmed by specific real-time polymerase ...
Khazeni et al. (1) concludes that H1N1 vaccination of 40% of the American population would ... Ghani AC Fraser C Kent CK Finelli L Ferguson NM. Household transmission of 2009 pandemic influenzaA(H1N1)virus...
Objective: To estimate the effectiveness and cost-effectiveness of pandemic influenza (H1N1) vaccination under different scenarios in October or November 2009. ... The model makes several assumptions that may not bear out given the unpredictability of H1N1 infection this fall. However users can test their own ...
affiliations of the previously anonymous members of the emergency committee that has been advising the agency on pandemic H1N1 influenza. ... published in June. That story addressed concerns predating the H1N1 pandemic about undeclared relationships with industry among WHO advisers. ...
The pandemic H1N1influenzavirus is similar to seasonal influenza A viruses in terms of viral shedding symptoms and household transmission ... epidemiologic data from affected countries suggest that pandemic 2009 H1N1virus infection is not on average a more severe illness than ...
WASHINGTON -- The FDA approved a new test for diagnosing the 2009 H1N1fluvirus developed by the CDC replacing a test panel approved in April 2009. The new test -- the CDC Influenza 2009 A (H1N1)pdm Real-Time RT-PCR Panel (IVD) ...